Observational studyJournal of neurology2023

Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study.

Nicola Capasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.